MGIA
REGN icon

Moneta Group Investment Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Moneta Group Investment Advisors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$313K Buy
502
+24
+5% +$16.3K ﹤0.01% 680
2026
Q1 		$370K Buy
478
+51
+12% +$39K ﹤0.01% 578
2025
Q4 		$330K Sell
427
-16
-4% -$10.9K ﹤0.01% 610
2025
Q3 		$249K Sell
443
-7
-2% -$3.96K ﹤0.01% 679
2025
Q2 		$236K Sell
450
-340
-43% -$190K ﹤0.01% 620
2025
Q1 		$501K Buy
790
+39
+5% +$26.8K 0.01% 419
2024
Q4 		$535K Sell
751
-107
-12% -$89.8K 0.01% 400
2024
Q3 		$902K Buy
858
+21
+3% +$23.4K 0.01% 290
2024
Q2 		$880K Buy
837
+159
+23% +$154K 0.01% 285
2024
Q1 		$653K Buy
678
+109
+19% +$104K 0.01% 329
2023
Q4 		$500K Sell
569
-2
-0.4% -$1.65K 0.01% 340
2023
Q3 		$470K Sell
571
-3
-0.5% -$2.36K 0.01% 330
2023
Q2 		$412K Sell
574
-69
-11% -$53.2K 0.01% 365
2023
Q1 		$528K Buy
643
+127
+25% +$95.8K 0.01% 314
2022
Q4 		$391K Sell
516
-489
-49% -$361K 0.01% 331
2022
Q3 		$692K Sell
1,005
-2
-0.2% -$1.26K 0.03% 227
2022
Q2 		$595K Buy
1,007
+453
+82% +$294K 0.02% 278
2022
Q1 		$387K Buy
+554
New +$350K 0.02% 322

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Moneta Group Investment Advisors's REGN Position: Q2 2026 in Review

Moneta Group Investment Advisors increased its Regeneron Pharmaceuticals (REGN) stake by 5% in Q2 2026, buying an estimated $16.3K and bringing the position to 502 shares worth $313K. The position accounts for ﹤0.01% of the portfolio, ranked #680.

Moneta Group Investment Advisors first reported a position in REGN in Q1 2022 and has held it in 18 quarters since. The position peaked at $902K in Q3 2024. 1,336 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Moneta Group Investment Advisors held 502 shares of Regeneron Pharmaceuticals worth $313K as of Q2 2026.
  • Moneta Group Investment Advisors bought 24 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $16.3K.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Moneta Group Investment Advisors's portfolio in Q2 2026, its #680 holding.
  • Moneta Group Investment Advisors first reported a position in Regeneron Pharmaceuticals in Q1 2022 and has held it in 18 quarters since.
  • Moneta Group Investment Advisors's Regeneron Pharmaceuticals position peaked at $902K in Q3 2024.
  • 1,336 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Moneta Group Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.